Search Medical Condition
Please enter condition
Please choose location
Clear Trial Filters
 

Irritable Bowel Syndrome (IBS) Clinical Trials

A listing of Irritable Bowel Syndrome (IBS) medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (10) clinical trials

Do you suffer from Irritable Bowel Syndrome with Diarrhea? We are currently conducting a Phase III clinical trial in the Miami-area for male/female patients, 18 years or older. Individuals who qualify will receive study medication and all study-related care at no charge. Compensation for study-related travel and time will be ...

Phase

If you've been diagnosed with Irritable Bowel Syndrome with Diarrhea (IBS-D), you can help local doctors evaluate an investigational medication as part of the IRIS study.

Phase

Do you have uncomfortable bloating? Feeling gassy all the time? Having less than 3 bowel movements in a week? You might have irritable bowel syndrome. You may qualify to participate in a research study at Boston Clinical Trials with new investigational medication for irritable bowel syndrome with constipation. (IBS-C)

Phase

A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients with Irritable Bowel Syndrome with Constipation (IBS-C)

Phase

A 12-week research study to test the safety and effectiveness of an investigational medication for the treatment of Irritable Bowel Syndrome with Constipation.

Phase

During the 12-week treatment period, subjects will record daily assessments including: frequency and timing of bowel movements; sensation and complete bowel emptying; consistency of bowel movements; degree of straining, worst abdominal pain, abdominal discomfort, abdominal bloating, abdominal fullness and abdominal cramping. Subjects will also record weekly assessments including: adequate relief ...

Phase

A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor (study medication) for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C).

Phase

A Long-Term Safety Study of Tenapanor for the Treatment of IBS-C

During the treatment period of up to 39-weeks, subjects will return for study visits approximately every 13 weeks. Subjects will undergo safety assessments at these visits, which may include a physical exam, ECG, vital signs, and clinical labs. Adverse events and concomitant medications will be recorded. Medication compliance will be ...

Phase

The Effect of Long-Acting Mesalamine on Post-Infective Irritable Bowel Syndrome- A Pilot Study

This study will test long acting mesalamine in the management of PI-IBS. It has the potential to improve QOL and perhaps gastrointestinal symptoms, in patients with PI-IBS. The results of this study, if positive, will provide preliminary data for a large scale clinical trial. This study will also provide information ...

Phase